This is a demo store. No orders will be fulfilled.

Azintuxizumab (anti-SLAMF7) - Primary antibody, specific to SLAMF7, Human IgG1

    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • Host species: Human
  • Reactive species: Cynomolgus monkey,Human
  • Isotype: Human IgG1
  • Conjugation: Unconjugated
In stock
Item Number
Ab190144
Grouped product items
SKU Size
Availability
Price Qty
Ab190144-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$109.90
Ab190144-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$519.90
Ab190144-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,299.90
Ab190144-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,079.90

Purity≥95% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Unconjugated

Basic Description

Product Name Azintuxizumab (anti-SLAMF7) - Primary antibody, specific to SLAMF7, Human IgG1
Synonyms 19A antibody19A24 protein antibody | CD 319 antibody | CD2 like receptor activating cytotoxic cells antibody | CD2 subset 1 antibody | CD319 antibody | CD319 antigen antibody | CRACC antibody | CS1 antibody | Membrane protein FOAP 12 antibody | Novel Ly9
Specifications & Purity Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Host species Human
Specificity SLAMF7
Conjugation Unconjugated
Grade Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Product Description

Azintuxizumab (anti-SLAMF7) is an anti-SLAMF7 human IgG1κ monoclonal antibody. Azintuxizumab (anti-SLAMF7) can be used in the synthesis of antibody-drug conjugate (ADC), Azintuxizumab vedotin.

Product Properties

Isotype Human IgG1
Light Chain Type kappa
SDS-PAGE 145.32 kDa
Purification Method Protein A purified
Concentration See COA
Storage Temp Store at -80°C,Avoid repeated freezing and thawing
Shipped In Ice chest + Ice pads
Stability And Storage Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
CAS 1826819-57-1

Associated Targets(Human)

SLAMF7 Tclin SLAM family member 7 (0 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)

Mechanisms of Action

Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References

Images

Azintuxizumab (anti-SLAMF7) (Ab190144) - Flow Cytometry
Flow Cytometry analysis of MM1.S cells labelling SLAMF7 with Azintuxizumab (anti-SLAMF7) (Ab190144) at 1×105 cell/well, with the EC₅₀ is 0.155 μg/mL.

Azintuxizumab (anti-SLAMF7) (Ab190144) - ELISA
Immobilized Recombinant Human SLAMF7/CRACC protein (rp181619) at 1.0 μg/mL can bind Azintuxizumab (anti-SLAMF7) (Ab190144) with the EC₅₀ of 343.9 ng/mL.

Azintuxizumab (anti-SLAMF7) (Ab190144) - SEC
The purity of Azintuxizumab (anti-SLAMF7) (Ab190144) is more than 95% verified by HPLC.

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.